Literature DB >> 389777

Differentiation of functionally active mouse T lymphocytes from functionally inactive bone marrow precursors. IV. Recovery of T-cell function from bone marrow precursors in a histo-incompatible environment.

R M Gorczynski, S Macrae.   

Abstract

Regeneration of T-cell activities in vivo or in vitro from mouse bone marrow precursors differentiating in the presence of an allogeneic thymus was investigated. The data indicated that T-depleted bone marrow cells fail to affect long-term reconstitution of allogeneic recipients unless a pool of rapidly maturing T-precursor cells is also removed (post-thymic pool). Animals reconstituted with pre-thymic bone marrow stem cells become stable chimaeras in which cells capable of generating an in vitro CML response to host antigens, as well as cells capable of suppressing that response, could be demonstrated. Similar data (CML directed against the H-2 antigens of the 'host' thymus feeder layer and cells capable of inhibiting that response) were obtained when pre-thymic bone marrow cells were grown in vitro on allogeneic thymus feeder cells. When cytotoxic T-lymphocyte precursor (CTLp) and helper (CTLh) cells were separately investigated, a restriction in their co-operation for an anti-host response was observed when precursor cells differentiated in an allogeneic environment. Only CTLp and CTLh differentiating in the presence of the same allogeneic thymus source (whether in vivo or in vitro) could co-operate to generate CTL directed to H-2 antigens of that thymus source.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389777      PMCID: PMC1457880     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Suppressor T cells in mice made unresponsive to skin allografts.

Authors:  P J Kilshaw; L Brent; M Pinto
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

2.  Immune competence of splenic lymphocytes following graft-vs-host disease in mouse allogeneic radiation chimeras.

Authors:  P Urso; N Gengozian
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

3.  THE IMMUNE STATUS OF LONG-TERM SURVIVORS OF LETHALLY X-IRRADIATED MICE PROTECTED WITH ISOLOGOUS, HOMOLOGOUS, OR HETEROLOGOUS BONE MARROW.

Authors:  N Gengozian; T Makinodan; C C Congdon; R D Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1958-06       Impact factor: 11.205

4.  In a radiation chimaera, host H-2 antigens determine immune responsiveness of donor cytotoxic cells.

Authors:  M J Bevan
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

5.  Cytotoxic T cells learn specificity for self H-2 during differentiation in the thymus.

Authors:  R M Zinkernagel; G N Callahan; J Klein; G Dennert
Journal:  Nature       Date:  1978-01-19       Impact factor: 49.962

6.  Evidence for in vivo protection against murine-sarcoma virus-induced tumors by T lymphocytes from immune animals.

Authors:  R M Gorczynski
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

7.  Bone marrow transplantation in patients with acute leukaemia.

Authors:  H Abu-Zahra; D Amato; M T Aye; D E Bergsagel; A M Clarysse; D H Cowan; V L Fornasier; R Hasselback; N N Iscove; E A McCulloch; H Messner; R G Miller; R A Phillips; A H Ragab; W D Rider; J S Senn
Journal:  Ser Haematol       Date:  1972

8.  The effects of anti-theta antiserum upon graft-versus-host activity of spleen and lymph node cells.

Authors:  H Cantor
Journal:  Cell Immunol       Date:  1972-03       Impact factor: 4.868

9.  Variation in T and B cell deficiency in different mouse allogeneic radiation chimeras.

Authors:  P Urso; N Gengozian
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

10.  Differentiation of functionally active mouse T lymphocytes from functionally inactive bone marrow precursors II. Limited recovery of T-cell responses from mouse bone marrow in tissue culture.

Authors:  M Gorczynski; S MacRae
Journal:  Immunology       Date:  1977-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.